Variant report
Variant | nsv520800 |
---|---|
Chromosome Location | chr8:51365953-51371910 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13258880 | chr8:51365953-51365954 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
2 | rs575553283 | chr8:51365960-51365961 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141902096 | chr8:51365962-51365963 | Bivalent Enhancer Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs118142839 | chr8:51366015-51366016 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561197578 | chr8:51366021-51366022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528420058 | chr8:51366034-51366035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550003824 | chr8:51366035-51366036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs16914917 | chr8:51366036-51366037 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs559708465 | chr8:51366096-51366097 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533129395 | chr8:51366122-51366123 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551899831 | chr8:51366124-51366125 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs143526831 | chr8:51366155-51366156 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12114446 | chr8:51366162-51366163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs549144358 | chr8:51366177-51366178 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567491582 | chr8:51366222-51366223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186550670 | chr8:51366269-51366270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs6984653 | chr8:51366292-51366293 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs146755737 | chr8:51366294-51366295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577567685 | chr8:51366295-51366296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529220612 | chr8:51366376-51366377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs149741100 | chr8:51366388-51366389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538251540 | chr8:51366397-51366398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557056117 | chr8:51366402-51366403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs6988898 | chr8:51366424-51366425 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs542718681 | chr8:51366431-51366432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189755767 | chr8:51366439-51366440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs147724898 | chr8:51366502-51366503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs117027116 | chr8:51366514-51366515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540524639 | chr8:51366558-51366559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565031394 | chr8:51366576-51366577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574433387 | chr8:51366646-51366647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545059664 | chr8:51366670-51366671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140514441 | chr8:51366683-51366684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs77951698 | chr8:51366732-51366733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs530931766 | chr8:51366741-51366742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549032030 | chr8:51366783-51366784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567528753 | chr8:51366784-51366785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs528613912 | chr8:51366794-51366795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182454203 | chr8:51366815-51366816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187926912 | chr8:51366838-51366839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs192557428 | chr8:51366839-51366840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs556706398 | chr8:51366854-51366855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568837587 | chr8:51366863-51366864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536364677 | chr8:51366881-51366882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183278264 | chr8:51366931-51366932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs187349462 | chr8:51366984-51366985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34179165 | chr8:51367008-51367009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs573122236 | chr8:51367084-51367085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540044335 | chr8:51367116-51367117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs558847648 | chr8:51367127-51367128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
22q11 deletion syndrome | 20357662 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:51364800-51366200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
2 | chr8:51364800-51369800 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr8:51365600-51366000 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
4 | chr8:51365800-51366000 | Bivalent Enhancer | H9 Cell Line | embryonic stem cell |
5 | chr8:51365800-51375800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
6 | chr8:51366200-51369000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
7 | chr8:51369000-51370600 | Strong transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
8 | chr8:51369400-51370400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
9 | chr8:51369800-51370200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
10 | chr8:51369800-51370600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr8:51370600-51374400 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |